Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 401–500 of 1,009
Shao, B., & Heinecke, J. W. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1402680 · Cited by 59
Proteomics for Biomarker Identification and Clinical Application in Kidney Disease
Chen, L., Su, W. C., Chen, H., Chen, D., Wang, M., Guo, Y. P., & Zhao, Y. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.02.005 · Cited by 59
Probing the Virtual Proteome to Identify Novel Disease Biomarkers
Mosley, J. D., Benson, M. D., Smith, J. G., Melander, O., Ngo, D., Shaffer, C. M., Ferguson, J. F., Herzig, M. S., McCarty, C. A., Chute, C. G., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.036063 · Cited by 52
Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
Esposito, C. L., Catuogno, S., Condorelli, G., Ungaro, P., & de Franciscis, V. (2018) · Genes · doi:10.3390/genes9110529 · Cited by 58
Direct digital sensing of protein biomarkers in solution
Krainer, G., Saar, K. L., Arter, W. E., Welsh, T. J., Czekalska, M. A., Jacquat, R. P. B., Peter, Q. A. E., Traberg, W. C., Pujari, A., Jayaram, A. K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35792-x · Cited by 61
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children
Hathout, Y., Conklin, L. S., Seol, H., Gordish‐Dressman, H., Brown, K. J., Morgenroth, L. P., Nagaraju, K., Heier, C. R., Damsker, J. M., van den Anker, J. N., et al. (2016) · Scientific Reports · doi:10.1038/srep31727 · Cited by 53
Vitamin B12 deficiency and impaired expression of amnionless during aging
Pannérec, A., Migliavacca, E., Castro, A. D., Michaud, J., Karaz, S., Goulet, L., Rezzi, S., Ng, T. P., Bosco, N., Larbi, A., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12260 · Cited by 63
Chirinos, J. A., Cohen, J. B., Zhao, L., Hanff, T. C., Sweitzer, N. K., Fang, J. C.-T., Corrales‐Medina, V., Ammar, R., Morley, M. P., Zamani, P. L., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15829 · Cited by 55
Kraemer, S., Schneider, D. J., Paterson, C., Perry, D., Westacott, M. J., Hagar, Y., Katilius, E., Lynch, S. A., Russell, T. M., Johnson, T., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00411 · Cited by 57
Self-citationKiddle, S. J., Steves, C. J., Mehta, M. A., Simmons, A., Xu, X., Newhouse, S., Sattlecker, M., Ashton, N. J., Bazenet, C. E., Killick, R., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.78 · Cited by 52
“be measured simultaneously and has already been applied in AD research [8-11].”
BackgroundSelf-citationAptamers: Molecular Tools for Medical Diagnosis
Özalp, V. C., Kavruk, M., Dilek, Ö., & Bayraç, A. T. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150413154233 · Cited by 58
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
Voyle, N., Baker, D., Burnham, S. C., Covin, A., Zhang, Z., Sangurdekar, D. P., Tan Hehir, C. A., Bazenet, C., Lovestone, S., Kiddle, S., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150020 · Cited by 50
Monteith, S., Glenn, T., Geddes, J., Whybrow, P. C., & Bauer, M. (2016) · International Journal of Bipolar Disorders · doi:10.1186/s40345-016-0051-7 · Cited by 50
Nishikawa, A., Suzuki, K., Kassai, Y., Gotou, Y., Takiguchi, M., Miyazaki, T., Yoshimoto, K., Yasuoka, H., Yamaoka, K., Morita, R., et al. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1006-1 · Cited by 60
Wasiak, S., Gilham, D., Tsujikawa, L. M., Halliday, C., Calosing, C., Jahagirdar, R., Johansson, J., Sweeney, M., Wong, N. C. W., & Kulikowski, E. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9755-z · Cited by 54
“units, which are directly proportional to the amount of target protein in the initial sample, were measured relative to baseline [15].”
BackgroundWells, Q. S., Gupta, D. K., Smith, J. G., Collins, S. P., Storrow, A. B., Ferguson, J., Smith, M. L., Pulley, J. M., Collier, S., Wang, X., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.074 · Cited by 51
“Antiplatelet med 651 (50) 301 (73) 292 (51) 58 (18)”
MethodKobayashi, H. H., Looker, H. C., Satake, E., Saulnier, P., Dom, Z. I. M., O’Neil, K. V., Ihara, K., Krolewski, B., Gałecki, A. T., Niewczas, M. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.04.022 · Cited by 54
Systematic Selection of Modified Aptamer Pairs for Diagnostic Sandwich Assays
Ochsner, U. A., Green, L. S., Gold, L., & Janjić, N. (2014) · BioTechniques · doi:10.2144/000114134 · Cited by 50
Self-citationSearching for New Biomarkers of Renal Diseases through Proteomics
Konvalinka, A., Scholey, J. W., & Diamandis, E. P. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165969 · Cited by 55
Rapid Histochemistry Using Slow Off-rate Modified Aptamers With Anionic Competition
Gupta, S., Thirstrup, D. J., Jarvis, T. C., Schneider, D. J., Wilcox, S. K., Carter, J., Zhang, C., Gelinas, A. D., Weiss, A., Janjić, N., et al. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3182008c29 · Cited by 50
Self-citationWestwood, S., Liu, B., Baird, A. L., Anand, S. N., Nevado‐Holgado, A. J., Newby, D., Pikkarainen, M., Hallikainen, M., Kuusisto, J., Streffer, J. R., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0258-6 · Cited by 53
Role of Novel Drug Delivery Vehicles in Nanobiomedicine
Tyagi, R. K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.77468 · Cited by 59
Roberts, J. A., Varma, V. R., An, Y., Varma, S., Candia, J., Fantoni, G., Tiwari, V., Anerillas, C., Williamson, A., Saito, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi8178 · Cited by 49
Komarova, N. V., Panova, O. S., Titov, A., & Kuznetsov, A. E. (2022) · Biomedicines · doi:10.3390/biomedicines10051085 · Cited by 51
“Gold’s group, SOMAmers were developed for a few thousand protein targets [272,273], with almost all the above-discussed cardiac biomarkers being among them [274], with the possible exception of neurohumoral markers (copeptin, MR-proADM, MR-proANP) as we did not find any mention of these in the scientific literature.”
BackgroundAffinity proteomics: the role of specific binding reagents in human proteome analysis
Stoevesandt, O., & Taussig, M. (2012) · Expert Review of Proteomics · doi:10.1586/epr.12.34 · Cited by 56
The Application of Aptamers in Cancer Research: An Up-to-Date Review
Hu, M., & Zhang, K.-H. (2013) · Future Oncology · doi:10.2217/fon.12.201 · Cited by 49
Improved scaffold biocompatibility through anti-Fibronectin aptamer functionalization
Galli, C., Parisi, L., Piergianni, M., Smerieri, A., Passeri, G., Guizzardi, S., Costa, F., Lumetti, S., Manfredi, E., & Macaluso, G. M. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.035 · Cited by 53
Pierson, S. K., Shenoy, S. A., Oromendia, A. B., Gorzewski, A. M., Pai, R.-A. L., Nabel, C. S., Ruth, J. R., Parente, S. A. T., Arenas, D. J., Guilfoyle, M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020004016 · Cited by 56
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease
Ozen, A., Kasap, N., Vujkovic-Cvijin, I., Apps, R., Cheung, F., Karakoç-Aydıner, E., Akkelle, B. Ş., Sarı, S., Tutar, E., Özçay, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00830-z · Cited by 50
Park, J. H., Jee, M. H., Kwon, O. S., Keum, S. J., & Jang, S. K. (2013) · Virology · doi:10.1016/j.virol.2013.01.014 · Cited by 48
Plasma Biomarkers for Alzheimer’s Disease: Much Needed But Tough to Find
Bazenet, C. E., & Lovestone, S. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.48 · Cited by 51
Isotachophoresis applied to biomolecular reactions
Eid, C., & Santiago, J. G. (2018) · Lab on a Chip · doi:10.1039/c7lc00852j · Cited by 52
Oligonucleotide aptamers against tyrosine kinase receptors: Prospect for anticancer applications
Camorani, S., Crescenzi, E., Fedele, M., & Cerchia, L. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.03.003 · Cited by 53
Michelsen, T. M., Henriksen, T., Reinhold, D., Powell, T. L., & Jansson, T. (2018) · The FASEB Journal · doi:10.1096/fj.201801193r · Cited by 58
Gadd, D. A., Hillary, R. F., McCartney, D. L., Shi, L., Stolicyn, A., Robertson, N., Walker, R. M., McGeachan, R. I., Campbell, A., Shen, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32319-8 · Cited by 48
Wang, X., Yip, K. C., He, A., Tang, J., Liu, S., Yan, R., Zhang, Q., & Li, R. (2022) · Journal of Proteome Research · doi:10.1021/acs.jproteome.2c00544 · Cited by 50
Wall, N. A., Chue, C. D., Edwards, N. C., Pankhurst, T., Harper, L., Steeds, R. P., Lauder, S. N., Townend, J., Moss, P. A. H., & Ferro, C. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055686 · Cited by 54
DNA Origami Meets Bottom-Up Nanopatterning
Martynenko, I. V., Ruider, V., Dass, M., Liedl, T., & Nickels, P. C. (2021) · ACS Nano · doi:10.1021/acsnano.1c04297 · Cited by 46
van de Wetering, C., Manuel, A. M., Sharafi, M., Aboushousha, R., Qian, X., Erickson, C. S., MacPherson, M. B., Chan, G. J., Adcock, I. M., Kermani, N. Z., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102160 · Cited by 50
“Sputum cells were studied by the SOMAscan proteomic assay [27,28].”
MethodSivakumar, P., Ammar, R., Thompson, J. R., Luo, Y., Streltsov, D., Porteous, M. K., McCoubrey, C., Cantu, E., Beers, M. F., Járai, G., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01860-3 · Cited by 54
Towards applications of synthetic genetic polymers in diagnosis and therapy
Taylor, A. I., Arangundy‐Franklin, S., & Holliger, P. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.09.022 · Cited by 46
Vezeau, G. E., Gadila, L. R., & Salis, H. M. (2023) · Nature Communications · doi:10.1038/s41467-023-38098-0 · Cited by 55
Ali, M., Erabadda, B., Chen, Y., Xu, Y., Gong, K., Liu, M., Binette, A. P., Timsina, J., Western, D., Yang, C., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03833-1 · Cited by 76
Nucleic Acids for Ultra-Sensitive Protein Detection
Janssen, K. P. F., Knez, K., Spasić, D., & Lammertyn, J. (2013) · Sensors · doi:10.3390/s130101353 · Cited by 55
Deep molecular phenotypes link complex disorders and physiological insult to CpG methylation
Zaghlool, S. B., Mook‐Kanamori, D. O., Kader, S. A., Stephan, N., Halama, A., Engelke, R., Sarwath, H., Al‐Dous, E., Mohamoud, Y. A., Roemisch‐Margl, W., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy006 · Cited by 59
Titz, B., Gadaleta, R. M., Sasso, G. L., Elamin, A., Ekroos, K., Ivanov, N. V., Peitsch, M. C., & Hoeng, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092775 · Cited by 49
Dong, L., Zhou, H., Zhao, M., Gao, X., Liu, Y., Liu, D., Guo, W., Hu, H., Xie, Q. R., Fan, J., et al. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.09.013 · Cited by 46
Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders
Khan, I., Kumari, P., Fernandes, V., Khatri, D. K., & Singh, S. B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01093-4 · Cited by 53
Microfluidic approaches to rapid and efficient aptamer selection
Lin, H., Zhang, W., Jia, S., Guan, Z., Yang, C. J., & Zhu, Z. (2014) · Biomicrofluidics · doi:10.1063/1.4890542 · Cited by 45
Immunocapture strategies in translational proteomics
Fredolini, C., Byström, S., Pin, E., Edfors, F., Tamburro, D., Iglesias, M. J., Månberg, A., Hong, M., Uhlén, M., Nilsson, P., et al. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1111141 · Cited by 55
Groote, M. A. D., Higgins, M. P., Hraha, T. H., Wall, K. M., Wilson, M. L., Sterling, D. G., Janjić, N., Reves, R. R., Ochsner, U. A., & Belknap, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01646-16 · Cited by 46
Self-citationKalra, P., Mishra, S. K., Kaur, S., Kumar, A., Prasad, H. K., Sharma, T. K., & Tyagi, J. S. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.08.011 · Cited by 44
Masvekar, R., Wu, T., Kosa, P., Barbour, C., Fossati, V., & Bielekova, B. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.11.032 · Cited by 45
Filippi, L., Bagni, O., & Nervi, C. (2020) · Expert Review of Medical Devices · doi:10.1080/17434440.2020.1796633 · Cited by 45
Panyard, D. J., McKetney, J., Deming, Y. K., Morrow, A. R., Ennis, G. E., Jonaitis, E. M., Van Hulle, C. A., Yang, C., Sung, Y. J., Ali, M., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13130 · Cited by 44
Trends in the Design and Development of Specific Aptamers Against Peptides and Proteins
Tabarzad, M., & Jafari, M. (2016) · The Protein Journal · doi:10.1007/s10930-016-9653-2 · Cited by 47
Eid, C., Palko, J. W., Katilius, E., & Santiago, J. G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00886 · Cited by 47
Self-citationBilling, A. M., Ben Hamidane, H., Bhagwat, A. M., Cotton, R. J., Dib, S. S., Kumar, P., Hayat, S., Goswami, N., Suhre, K., Rafii, A., et al. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2016.08.023 · Cited by 44
Tonry, C. L., Finn, S. P., Armstrong, J., & Pennington, S. R. (2020) · Clinical Proteomics · doi:10.1186/s12014-020-09305-7 · Cited by 52
Satake, E., Saulnier, P., Kobayashi, H. H., Gupta, M. K., Looker, H. C., Wilson, J. M., Dom, Z. I. M., Ihara, K., O’Neil, K. V., Krolewski, B., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021010105 · Cited by 44
“SOMAscan: Aptamer-Based Proteomics Platform Unique, single-stranded sequences ofDNAandRNA, referred to as aptamers, recognize folded protein epitopes with high affinity and specificity.(25,26) This property was further advanced by using slow off-rate modified aptamers to develop the SOMAscan platform (SomaLogic, Denve…”
MethodPlasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
Matías‐García, P. R., Wilson, R., Guo, Q., Zaghlool, S. B., Eales, J., Xu, X., Charchar, F. J., Dormer, J., Maalmi, H., Schlosser, P., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071070 · Cited by 47
Aptamers against viruses: Selection strategies and bioanalytical applications
Sánchez-Báscones, E., Parra, F., & Lobo-Castañón, M. J. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116349 · Cited by 44
Kobayashi, H. H., Looker, H. C., Satake, E., D’Addio, F., Wilson, J. M., Saulnier, P., Dom, Z. I. M., O’Neil, K. V., Ihara, K., Krolewski, B., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abj2109 · Cited by 48
Fluorescence Anisotropy Reduction of Allosteric Aptamer for Sensitive and Specific Protein Signaling
Zhang, D., Zhao, Q., Zhao, B., & Wang, H. (2012) · Analytical Chemistry · doi:10.1021/ac3004133 · Cited by 43
Sanges, S., Rice, L. M., Tu, L., Valenzi, E., Cracowski, J., Montani, D., Mantero, J. C., Ternynck, C., Marot, G., Bujor, A. M., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223237 · Cited by 49
Functionally Enhanced XNA Aptamers Discovered by Parallelized Library Screening
Lozoya‐Colinas, A., Yu, Y., & Chaput, J. C. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c09497 · Cited by 46
Disruption of the cerebrospinal fluid–plasma protein balance in cognitive impairment and aging
Farinas, A., Rutledge, J., Bot, V. A., Western, D., Ying, K., Lawrence, K. A., Oh, H. S., Yoon, S., Ding, D. Y., Tsai, A. P., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03831-3 · Cited by 61
Chemical Morphing of DNA Containing Four Noncanonical Bases
Eremeeva, E., Abramov, M., Margamuljana, L., Rozenski, J., Pezo, V., Marlière, P., & Herdewijn, P. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601529 · Cited by 44
Development of a Protein Biomarker Panel to Detect Non–Small-Cell Lung Cancer in Korea
Jung, Y. J., Katilius, E., Ostroff, R. M., Kim, Y., Seok, M., Lee, S., Jang, S., Kim, W. S., & Choi, C. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.09.012 · Cited by 48
Self-citationMueller, S. K., Nocera, A. L., Dillon, S. T., Gu, X., Wendler, O., Otu, H. H., Libermann, T. A., & Bleier, B. S. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22226 · Cited by 45
Protein Sequencing, One Molecule at a Time
Floyd, B. M., & Marcotte, E. M. (2022) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-102121-103615 · Cited by 51
Thareja, G., Belkadi, A., Arnold, M., Albagha, O., Graumann, J., Schmidt, F., Grallert, H., Peters, A., Gieger, C., & Suhre, K. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac243 · Cited by 49
Lindbohm, J. V., Mars, N., Sipilä, P. N., Singh‐Manoux, A., Runz, H., FinnGen, Livingston, G., Seshadri, S. S., Xavier, R. J., Hingorani, A. D., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00293-x · Cited by 43
Frick, E. A., Emilsson, V., Jónmundsson, Þ., Steindorsdottir, A. E., Johnson, E. C. B., Puerta, R., Dammer, E. B., Shantaraman, A., Cano, A. C., Boada, M., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00693-1 · Cited by 50
Catch and measure–mass spectrometry‐based immunoassays in biomarker research
Weiß, F., van den Berg, B. H. J., Planatscher, H., Pynn, C. J., Joos, T. O., & Poetz, O. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.09.010 · Cited by 42
Wu, D., Katilius, E., Olivas, E., Milutinovic, M. D., & Walt, D. R. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02451 · Cited by 45
Self-citationHirao, I., Kimoto, M., & Lee, K. H. (2017) · Biochimie · doi:10.1016/j.biochi.2017.09.007 · Cited by 46
Lim, S. Y., Lee, J. H., Welsh, S. J., Ahn, S. B., Breen, E., Khan, A., Carlino, M. S., Menzies, A. M., Kefford, R. F., Scolyer, R. A., et al. (2017) · Biomarker Research · doi:10.1186/s40364-017-0112-9 · Cited by 42
“The SOMAscan assay uses SOMAmer (Slow Off-rate Modified Aptamer) reagents, which consist of modified short DNA sequences that bind specific protein analytes [16].”
MethodNano-biosensing approaches on tuberculosis: Defy of aptamers
Golichenari, B., Nosrati, R., Farokhi‐Fard, A., Abnous, K., Vaziri, F., & Behravan, J. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.06.025 · Cited by 42
Ondruš, M., Sýkorová, V., Bednářová, L., Pohl, R., & Hocek, M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa999 · Cited by 43
Navajas, R., Corrales, F. J., & Paradela, A. (2021) · Clinical Proteomics · doi:10.1186/s12014-021-09313-1 · Cited by 47
A proteogenomic signature of age-related macular degeneration in blood
Emilsson, V., Gudmundsson, E. F., Jónmundsson, Þ., Jonsson, B. G., Twarog, M., Guðmundsdóttir, V., Li, Z., Finkel, N., Poor, S. H., Liu, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31085-x · Cited by 44
Using Artificial Intelligence to Better Predict and Develop Biomarkers
Michelhaugh, S. A., & Januzzi, J. L. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2021.11.004 · Cited by 46
Jarvis, T. C., Davies, D. R., Hisaminato, A., Resnicow, D. I., Gupta, S., Waugh, S. M., Nagabukuro, A., Wadatsu, T., Hishigaki, H., Gawande, B. N., et al. (2015) · Structure · doi:10.1016/j.str.2015.03.027 · Cited by 41
Self-citationA Candidate Plasma Protein Classifier to Identify Alzheimer's Disease
Zhao, X., Lejnine, S., Spond, J., Zhang, C., Ramaraj, T. C., Holder, D. J., Dai, H., Weiner, R., & Laterza, O. F. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-141149 · Cited by 41
Self-citationHamula, C. L. A., Peng, H., Wang, Z., Tyrrell, G. J., Li, X., & Le, X. C. (2015) · Methods · doi:10.1016/j.ymeth.2015.12.005 · Cited by 41
Benefit of Apabetalone on Plasma Proteins in Renal Disease
Wasiak, S., Tsujikawa, L. M., Halliday, C., Stotz, S. C., Gilham, D., Jahagirdar, R., Kalantar‐Zadeh, K., Robson, R. A., Sweeney, M., Johansson, J. O., et al. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.12.001 · Cited by 42
Identification of Plasma Proteome Signatures Associated With Surgery Using SOMAscan
Fong, T. G., Chan, N. Y., Dillon, S. T., Zhou, W., Tripp, B. A., Ngo, L. H., Otu, H. H., Inouye, S. K., Vasunilashorn, S. M., Cooper, Z. R., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003283 · Cited by 41
Transforming growth factor-β, MAPK and Wnt signaling interactions in colorectal cancer
Cheruku, H. R., Mohamedali, A., Cantor, D. I., Tan, S. H., Nice, E. C., & Baker, M. S. (2015) · EuPA Open Proteomics · doi:10.1016/j.euprot.2015.06.004 · Cited by 48
Preparation of Single-Stranded DNA from PCR Products with Streptavidin Magnetic Beads
Wilson, R. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0322 · Cited by 41
Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
Natrajan, M. S., Komori, M., Kosa, P., Johnson, K. R., Wu, T., Franklin, R. J. M., & Bielekova, B. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.260 · Cited by 40
Yan, X., Yang, L., & Wang, Q. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-6886-1 · Cited by 41
Farini, V. L., Camaño, C. V., Ybarra, G., Viale, D. L., Vichera, G. D., Yakisich, J. S., & Radrizzani, M. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.05.008 · Cited by 40
Association of a Serum Protein Signature With Rheumatoid Arthritis Development
O’Neil, L. J., Spicer, V., Smolik, I., Meng, X., Goel, R. R., Anaparti, V., Wilkins, J. A., & El-Gabalawy, H. S. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41483 · Cited by 43
Aptamers against Immunoglobulins: Design, Selection and Bioanalytical Applications
Bognár, Z., & Gyurcsányi, R. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165748 · Cited by 40
Predicting human health from biofluid-based metabolomics using machine learning
Evans, E. D., Duvallet, C., Chu, N. D., Oberst, M., Murphy, M. A., Rockafellow, I., Sontag, D. A., & Alm, E. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-74823-1 · Cited by 48
Hirota, M., Murakami, I., Ishikawa, Y., Suzuki, T. W., Sumida, S.-I., Ibaragi, S., Kasai, H., Horai, N., Drolet, D. W., Gupta, S., et al. (2015) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0567 · Cited by 43
Self-citationT cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVIDPreprint
Visvabharathy, L., Hanson, B. A., Orban, Z. S., Lim, P. H., Palacio, N. M., Jimenez, M., Clark, J. R., Graham, E. L., Liotta, E. M., Tachas, G., et al. (2021) · medRxiv · doi:10.1101/2021.08.08.21261763 · Cited by 43
Li, Q., Maola, V. A., Chim, N., Hussain, J., Lozoya‐Colinas, A., & Chaput, J. C. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c08649 · Cited by 41
Winchester, L. M., Lawton, M., Barber, I., Ash, J. A., Liu, B., Evetts, S. G., Hopkins‐Jones, L., Lewis, S., Bresner, C., Vingill, S., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac343 · Cited by 49
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.